{"title": "VERA FILES FACT CHECK: Duterte repeats false claim that vaccines are made from human body", "subtitle": "In his latest public address on the coronavirus disease 2019 (COVID-19) pandemic, President Rodrigo Duterte again wrongly claimed that vaccines are made from the human body.", "author": "verafiles.org", "date": "Aug 28, 2020, 7:44 PM", "vclaim_id": "vclaim-id-62149", "url": "https://verafiles.org/articles/vera-files-fact-check-duterte-repeats-false-claim-vaccines-a", "vclaim": "In his latest public address on the coronavirus disease 2019 (COVID-19) pandemic, President Rodrigo Duterte again wrongly claimed that vaccines are made from the human body.\n\nToward the end of his recorded address aired on Aug. 25, Duterte assured Filipinos that the government is \"doing everything\" to address the health crisis. He then said:\n\nA vaccine is a product that a \u201ckilled\u201d or \u201cweakened\u201d version, or parts, of a bacteria or virus that causes a particular disease, such as COVID-19. It is used to train the body\u2019s immune response to produce antibodies used to fight off pathogens, according to the World Health Organization (WHO). (See VERA FILES FACT CHECK: Five things you need to know about COVID-19 antibodies )\n\nAlthough vaccines are not made from the human body, people still play a role in their development, particularly in . Candidate vaccines are usually to see their efficacy and possible side effects, which are usually done in three stages prior to government approval. (See )\n\nThis infographic was first published by VERA Files Fact Check in May 2020.\n\nThere are at least 173 candidate vaccines for COVID-19, with 31 already in various stages of clinical trials as of Aug. 25, according to .\n\nAmong the frontrunners already in stage three trials, based on the WHO document, are the candidate vaccines of the United Kingdom-based University of Oxford and British-Swedish pharmaceutical firm Astrazeneca, and those of Chinese companies Sinovac Biotech Ltd., and Wuhan Institute of Biological Products with Sinopharm Group.\n\nRussia on Aug. 11 when it approved for public use a COVID-19 vaccine that has yet to complete its clinical trials, claiming it is the \u201c \u201d approved jab against COVID-19. Duterte has Russia\u2019s offer to participate in its phase three trials from October 2020 to March 2021 and to supply the Sputnik vaccine to the Philippines.\n\nHowever, the vaccine, developed by Moscow-based , met skepticism from experts, noting, among others, that it was registered after of research. (See VERA FILES FACT SHEET: The COVID-19 vaccine from Russia, in context )\n\nDuterte made a similar false claim in July when he said a vaccine is an \u201cantibody produced by the [human] body to fight infection.\u201d While the two are interrelated, they are not one and the same. Antibodies are proteins produced by the body\u2019s immune system when stimulated by a vaccine -- which contains either a \u201cweakened\u201d or killed version of the pathogen, or a part of it -- or through natural infection. (See )\n\nIn his about the COVID-19 crisis on Feb. 3, Duterte downplayed the problem, telling the public that the virus will just \u201cdie a natural death\u201d even without a vaccine. (See VERA FILES FACT CHECK: Duterte says he\u2019s been warning of \u2018deadly\u2019 COVID-19 from the beginning. Not quite. )\n\u2022 CNN, Putin says Russia has approved 'world first' Covid-19 vaccine. But questions over its safety remain , Aug. 11, 2020\n\u2022 BBC, Coronavirus: Putin says vaccine has been approved for use , Aug. 11, 2020\n\u2022 Business Today, First coronavirus vaccine: Why the world doubts Russia's claim , Aug. 14, 2020\n\u2022 CNBC, Russia coronavirus vaccine has been researched for six years , Aug, 12, 2020\n\nOfficial website of Sputnik V, About Us | Official website vaccine against COVID-19 Sputnik V. , Accessed Aug. 27, 2020\n\nPresidential Communications Operations Office, Philippines may acquire COVID-19 vaccine through loan, says President Duterte , Aug. 18, 2020\n\nRTVMalacanang, Briefing on the 2019 Novel Coronavirus - Acute Respiratory Disease 2/3/2020 , Feb. 3, 2020", "lang": "en"}